Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Total Debt: 2019-2025

Historic Total Debt for Biodesix (BDSX) over the last 5 years, with Sep 2025 value amounting to $47.1 million.

  • Biodesix's Total Debt rose 30.46% to $47.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.1 million, marking a year-over-year increase of 30.46%. This contributed to the annual value of $36.4 million for FY2024, which is 36.22% down from last year.
  • Biodesix's Total Debt amounted to $47.1 million in Q3 2025, which was up 0.70% from $46.8 million recorded in Q2 2025.
  • Biodesix's Total Debt's 5-year high stood at $57.1 million during Q4 2023, with a 5-year trough of $14.2 million in Q3 2022.
  • Its 3-year average for Total Debt is $43.3 million, with a median of $41.6 million in 2024.
  • As far as peak fluctuations go, Biodesix's Total Debt tumbled by 67.13% in 2022, and later skyrocketed by 212.42% in 2023.
  • Quarterly analysis of 5 years shows Biodesix's Total Debt stood at $27.8 million in 2021, then climbed by 27.34% to $35.3 million in 2022, then soared by 61.50% to $57.1 million in 2023, then plummeted by 36.22% to $36.4 million in 2024, then surged by 30.46% to $47.1 million in 2025.
  • Its Total Debt stands at $47.1 million for Q3 2025, versus $46.8 million for Q2 2025 and $36.7 million for Q1 2025.